RAYMOND JAMES & ASSOCIATES - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 242 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$850,000
+11.0%
33,149
+3.0%
0.00%0.0%
Q2 2022$766,000
-58.3%
32,198
-54.2%
0.00%
-50.0%
Q4 2020$1,838,000
+33.4%
70,264
-11.2%
0.00%0.0%
Q3 2020$1,378,000
-6.7%
79,166
-9.9%
0.00%0.0%
Q2 2020$1,477,000
+11.4%
87,831
-21.3%
0.00%0.0%
Q1 2020$1,326,000
-44.6%
111,532
-43.6%
0.00%
-33.3%
Q4 2019$2,392,000
+0.2%
197,664
+17.1%
0.00%0.0%
Q3 2019$2,387,000
+22.9%
168,857
-3.1%
0.00%0.0%
Q2 2019$1,943,000
+31.6%
174,259
+38.5%
0.00%
+50.0%
Q1 2019$1,477,000
-39.4%
125,781
-31.1%
0.00%
-50.0%
Q4 2018$2,438,000
+152.1%
182,520
+164.6%
0.00%
+300.0%
Q3 2018$967,000
+23.8%
68,977
+38.9%
0.00%0.0%
Q2 2018$781,000
+14.7%
49,670
+20.1%
0.00%0.0%
Q1 2018$681,000
-5.4%
41,368
+3.8%
0.00%0.0%
Q4 2017$720,000
-60.6%
39,863
-57.9%
0.00%
-75.0%
Q3 2017$1,829,000
+76.0%
94,748
+7.6%
0.00%
+100.0%
Q2 2017$1,039,000
+108.6%
88,028
+93.9%
0.00%
+100.0%
Q1 2017$498,00045,4000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,712,176$123,147,0006.01%
TANAKA CAPITAL MANAGEMENT INC 74,139$1,048,0003.38%
S&T BANK/PA 625,078$8,859,0001.92%
Parallel Advisors, LLC 1,277,851$18,062,0001.55%
AJ WEALTH STRATEGIES, LLC 595,828$8,422,0001.11%
Matarin Capital Management, LLC 891,636$12,603,0000.95%
Capital Impact Advisors, LLC 162,544$2,370,0000.90%
AMI ASSET MANAGEMENT CORP 775,685$10,964,0000.57%
Birchview Capital, LP 50,000$707,0000.47%
Zebra Capital Management LLC 25,409$359,0000.39%
View complete list of CORCEPT THERAPEUTICS INC shareholders